Summary
Machine-generated summaryAOK Bayern intends to conclude non-exclusive rebate agreements under Section 130a paragraph 8 SGB V with all interested pharmaceutical companies for the active substance Omalizumab, ATC R03DX05. This is not an open procedure but an open house model: identical, non-negotiable rebate agreements are offered to all companies meeting the eligibility criteria. Contracts can start from 01.10.2026, end on 30.09.2028, and may be joined until 03.08.2028, with one month's notice to month end. Companies must sign the contract, the annex listing the medicines, and a declaration of reliability.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago
More from this buyer
Full buyer profile103 open tenders right now
- Healthcare services - Video consultation service 1 day left
- Healthcare services - Video medical consultation 8 days left
- Call centre - Contract for call centre services for insured person communication on healthcare contracts 18 days left
This buyer has no award history in this sector yet. Usual winners, Medical equipment & pharmaceuticals - Germany
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| Siemens Healthineers AG | 42 | €17.4M | Sep 2026 |
| Philips GmbH | 20 | €5.3M | Sep 2026 |
| GlaxoSmithKline GmbH & Co. KG | 15 | n/a | Sep 2026 |
| ASTRAZENECA GMBH | 12 | n/a | Jul 2026 |
| Brainlab Sales GmbH | 10 | €4.0M | Sep 2026 |
Based on 1018 awards with a linked company profile over the last 2 years.
Similar tenders
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €10,072,234
- Buyer track record on Aperlena
- 168 notices tracked · 58 awarded
- €0 in awarded contracts
Never miss a tender like this
76 new notices in Medical equipment & pharmaceuticals in Germany in the last 7 days. Get an email when new ones appear. Free.
Set up my alert